Website
http://dataportal.arc.gov.au/NCGP/API/grants/DE180100484
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Tipping the balance from tolerance to immunity for the devil facial tumour. This project aims to develop a single-shot vaccine for the Tasmanian devil facial tumour disease. The disease is an enigma because the transmissible tumours are simultaneously cancer, infections, and genetically mismatched tissue grafts. This project will focus on immune molecules that are revolutionising human oncology, and will develop techniques to understand and systematically test the function of these key molecules in Tasmanian devils. Understanding the role of these immune molecules will accelerate development of a vaccine to help save the devil and has the potential to shed light on general principles relating to how the immune system balances tolerance and immunity.Funded Activity Details
Start Date: 2018
End Date: 12-2020
Funding Scheme: Discovery Early Career Researcher Award
Funding Amount: $365,058.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Zoology | Animal Immunology | Veterinary Immunology | Tumour Immunology
ANZSRC Socio-Economic Objective (SEO)
Expanding Knowledge in the Biological Sciences | Flora, Fauna and Biodiversity at Regional or Larger Scales |
